Directory
News
Genentech to Re-Introduce Susvimo for Wet AMD
Genentech is re-introducing Susvimo™, its port delivery system (PDS) for the treatment of wet age-related macular degeneration (AMD). The PDS, a refillable capsule the size of a rice grain, provides continual release of ranibizumab, a protein that blocks the growth of...
Beacon Doses First Patient in its Phase 2/3 VISTA Clinical Trial for XLRP Gene Therapy
Beacon Therapeutics, an ophthalmic gene therapy company, has dosed the first patient in its Phase 2/3 VISTA clinical trial for AGTC-501, an emerging gene therapy for X-linked retinitis pigmentosa (XLRP) caused by mutations in the gene RPGR. VISTA will enroll 75 males...
Antabuse Moves into Clinical Trial for People with RP
Disulfiram (aka, Antabuse), a drug approved by the US Food & Drug Administration (FDA) for deterring alcohol consumption, has moved into a clinical trial for potentially improving vision in people with retinitis pigmentosa (RP). The 30-participant,...
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
InGel Therapeutic’s emerging, innovative cellular treatment for preserving cone-mediated vision in people with...
ARVO 2024 Highlight: PYC Reports Initial Clinical Trial Results for its RNA Therapy Targeting RP (PRPF31 Mutations)
PYC Therapeutics, an Australia-based developer of RNA therapies, reported initial results from its Phase 1 PLATYPUS...
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
A team of genetic researchers from the UK, US, and Switzerland has identified a mutation in the gene TMEM216 as a...
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
EyeDNA Therapeutics, a subsidiary of Paris-based Coave Therapeutics, reported encouraging 24-month results for 17...
Events
YOUTUBE VIDEOS
-
2025 USABA National Goalball Qualifying TournamentsGear up for an unforgettable year of Goalball as teams compete for a chance to shine on the national stage! The 2025 USABA National Goalball Qualifier Tournaments are your pathway to the Goalball National Tournament, taking place in Colorado Springs, CO, in August 2025. Tournament Schedule: March 28-30, 2025... Read more -
Sustained Drug Delivery for Glaucoma: From Promise to Reality — Malik Kahook, MD, New Horizons ForumGlaucoma visionary Malik Kahook, MD, Chief of the Sue Anschutz-Rogers Eye Center at the University of Colorado School of Medicine, delivered the Sutro Memorial Lecture, the Forum’s keynote address. “Sustained Drug Delivery for Glaucoma: From Promise to Reality,” covers current drug delivery mechanisms as well as new and forthcoming ways... Read more -
What's Up with the Access Tech Book?https://www.youtube.com/watch?v=4tzXtSMwXrY Feeling overwhelmed by AT assessments? In this webinar Dr. Ting Siu will walk you through the Access Tech Book from APH Press. Overview the many forms and checklists to gain a better understanding of how they can be utilized when working with students. Instructor: Name: Dr. Yue-Ting Siu Title: ... Read more -
What's Up with the Access Tech Book?https://www.youtube.com/watch?v=4tzXtSMwXrY Feeling overwhelmed by AT assessments? In this webinar Dr. Ting Siu will walk you through the Access Tech Book from APH Press. Overview the many forms and checklists to gain a better understanding of how they can be utilized when working with students. Instructor: Name: Dr. Yue-Ting Siu Title: ... Read more -
The Future of Interventional Glaucoma: Ike Ahmad, MD, FRSC — New Horizons Forum 2024"The Future of Interventional Glaucoma" with Ike Ahmad, MD, FRSC is a featured session from New Horizons Forum, recorded on February 9, 2024 at the Westin St. Francis in San Francisco, Calif. laucoma 360 is presented by Glaucoma Research Foundation. Learn more at https://glaucoma360.org/ This video from New Horizons Forum... Read more -
Transforming Glaucoma Care: Addressing Unmet Needs - New Horizons Forum 2024"Transforming Glaucoma Care: Addressing Unmet Needs" is a featured session from New Horizons Forum, recorded on February 9, 2024 at the Westin St. Francis in San Francisco, Calif. Speakers include: Ronald Fellman, MD, Leon Herndon, Jr, MD, Rafael Chan, Jeffrey Goldberg, MD, PhD, Brandy Keys, MPH, and Tonian McDonald. Glaucoma... Read more -
Help Capture a $50,000 Collective Matching Donation for #GivingTuesday Dec. 311/19/2024 – Just 2 weeks away… Help us capture a $50,000 collective matching donation in this year’s #GivingTuesday and help to raise more than $200,000 during this global day of giving. Once again, Vermont Adaptive is participating in the nationally recognized charitable giving campaign, #GivingTuesday, on Tuesday, Dec. 3,... Read more -
NIH-led scientific team defines elements of brain-based visual impairment in childrenExperts convened by the National Institutes of Health (NIH) have identified five elements of a brain-based condition that has emerged as a leading cause of vision impairment starting in childhood in the United States and other industrialized nations. Read post Experts convened by the National Institutes of Health (NIH)... Read more -
Constant scanning / random rambles as to not spiralNot sure what to call this one or where to start but I need to know this is normal and I will get used to it. Is it normal for your mind and brain to be going so much all the time, like constantly scanning, constantly listening, constantly trying to... Read more
Podcasts
Dive into insightful conversations and empowering stories within the blind and low-vision community.
Groups
Connect with supportive online and in-person groups for the blind and low-vision community
Apps
Explore empowering apps designed for the blind and low-vision community—discover new possibilities